Satisfaction with ovarian carcinoma risk-reduction strategies among women at high risk for breast and ovarian carcinoma

Cancer

Volumn 117, Issue 12, 2011, Pages 2659-2667

  Westin, Shannon N ^a   Sun, Charlotte C ^a   Lu, Karen H ^a   Schmeler, Kathleen M ^a   Soliman, Pamela T ^a   Lacour, Robin A ^a   Johnson, Kristin G ^a   Daniels, Molly S ^a   Arun, Banu K ^a   Peterson, Susan K ^a   Bodurka, Diane C ^a  

^a UNIVERSITY OF TEXAS MD ANDERSON CANCER CENTER   (United States)

Author keywords

BRCA; breast cancer; ovarian cancer; risk reduction; satisfaction

Indexed keywords

ADULT; AGED; ARTICLE; BREAST CANCER; CANCER RISK; CANCER SCREENING; CONTROLLED STUDY; FEMALE; GENE EXPRESSION; GENE MUTATION; HIGH RISK PATIENT; HUMAN; MAJOR CLINICAL STUDY; OVARY CANCER; PATIENT DECISION MAKING; PATIENT SATISFACTION; PRIORITY JOURNAL; RISK REDUCTION; SALPINGOOOPHORECTOMY; TUMOR SUPPRESSOR GENE;

ADULT; AGED; AGED, 80 AND OVER; BREAST NEOPLASMS; DECISION MAKING; EARLY DETECTION OF CANCER; FALLOPIAN TUBES; FEMALE; HUMANS; MIDDLE AGED; OVARIAN NEOPLASMS; OVARIECTOMY; PATIENT SATISFACTION; PRIMARY PREVENTION; QUALITY OF LIFE; QUESTIONNAIRES; RISK REDUCTION BEHAVIOR;

EID: 79958854543     PISSN: 0008543X     EISSN: 10970142     Source Type: Journal    
DOI: 10.1002/cncr.25820     Document Type: Article

References (37)

1. Jemal A, Siegel R, Ward E, Hao Y, Xu J, Thun MJ,. Cancer statistics, 2009. CA Cancer J Clin. 2009; 59: 225-249.
2. Risch HA, McLaughlin JR, Cole DE, et al. Prevalence and penetrance of germline BRCA1 and BRCA2 mutations in a population series of 649 women with ovarian cancer. Am J Hum Genet. 2001; 68: 700-710. (Pubitemid 32203724)
3. Pal T, Permuth-Wey J, Betts JA, et al. BRCA1 and BRCA2 mutations account for a large proportion of ovarian carcinoma cases. Cancer. 2005; 104: 2807-2816. (Pubitemid 41798292)
4. Lux MP, Fasching PA, Beckmann MW,. Hereditary breast and ovarian cancer: review and future perspectives. J Mol Med. 2006; 84: 16-28. (Pubitemid 43099520)
5. Ries LAG, Harkins D, Krapcho M, et al. eds. SEER Cancer Statistics Review, 1975-2003, vol. 2008. Bethesda, MD: National Cancer Institute; 2006.
6. Boyd J,. Specific keynote: hereditary ovarian cancer: what we know. Gynecol Oncol. 2003; 88 (1 pt 2): S8-S10; discussion S11-S13.
7. Stratton JF, Pharoah P, Smith SK, Easton D, Ponder BA,. A systematic review and meta-analysis of family history and risk of ovarian cancer. Br J Obstet Gynaecol. 1998; 105: 493-499. (Pubitemid 28261378)
8. Bell R, Petticrew M, Sheldon T,. The performance of screening tests for ovarian cancer: results of a systematic review. Br J Obstet Gynaecol. 1998; 105: 1136-1147. (Pubitemid 28526195)
9. Rebbeck TR, Lynch HT, Neuhausen SL, et al. Prophylactic oophorectomy in carriers of BRCA1 or BRCA2 mutations. N Engl J Med. 2002; 346: 1616-1622. (Pubitemid 34755669)
10. Kauff ND, Satagopan JM, Robson ME, et al. Risk-reducing salpingo-oophorectomy in women with a BRCA1 or BRCA2 mutation. N Engl J Med. 2002; 346: 1609-1615. (Pubitemid 34755668)
11. Finch A, Beiner M, Lubinski J, et al. Salpingo-oophorectomy and the risk of ovarian, fallopian tube, and peritoneal cancers in women with a BRCA1 or BRCA2 mutation. JAMA. 2006; 296: 185-192.
12. Rebbeck TR, Kauff ND, Domchek SM,. Meta-analysis of risk reduction estimates associated with risk-reducing salpingo-oophorectomy in BRCA1 or BRCA2 mutation carriers. J Natl Cancer Inst. 2009; 101: 80-87.
13. Madalinska JB, Hollenstein J, Bleiker E, et al. Quality-of-life effects of prophylactic salpingo-oophorectomy versus gynecologic screening among women at increased risk of hereditary ovarian cancer. J Clin Oncol. 2005; 23: 6890-6898.
14. Swisher EM, Babb S, Whelan A, Mutch DG, Rader JS,. Prophylactic oophorectomy and ovarian cancer surveillance. Patient perceptions and satisfaction. J Reprod Med. 2001; 46: 87-94. (Pubitemid 32205249)
15. Schmeler KM, Sun CC, Bodurka DC, et al. Prophylactic bilateral salpingo-oophorectomy compared with surveillance in women with BRCA mutations. Obstet Gynecol. 2006; 108 (3 pt 1): 515-520. (Pubitemid 44337090)
16. Uyei A, Peterson SK, Erlichman J, et al. Association between clinical characteristics and risk-reduction interventions in women who underwent BRCA1 and BRCA2 testing: a single-institution study. Cancer. 2006; 107: 2745-2751. (Pubitemid 44937026)
17. Holmes-Rovner M, Kroll J, Schmitt N, et al. Patient satisfaction with health care decisions: the satisfaction with decision scale. Med Decis Making. 1996; 16: 58-64. (Pubitemid 26017908)
18. Lancaster JM, Powell CB, Kauff ND, et al. Society of Gynecologic Oncologists Education Committee statement on risk assessment for inherited gynecologic cancer predispositions. Gynecol Oncol. 2007; 107: 159-162. (Pubitemid 47575743)
19. Lerman C, Daly M, Masny A, Balshem A,. Attitudes about genetic testing for breast-ovarian cancer susceptibility. J Clin Oncol. 1994; 12: 843-850. (Pubitemid 24110927)
20. Fallowfield LJ, Leaity SK, Howell A, Benson S, Cella D,. Assessment of quality of life in women undergoing hormonal therapy for breast cancer: validation of an endocrine symptom subscale for the FACT-B. Breast Cancer Res Treat. 1999; 55: 189-199. (Pubitemid 29389581)
21. Thirlaway K, Fallowfield L, Cuzick J,. The Sexual Activity Questionnaire: a measure of women's sexual functioning. Qual Life Res. 1996; 5: 81-90. (Pubitemid 26100506)
22. Hopwood P, Fletcher I, Lee A, Al Ghazal S,. A body image scale for use with cancer patients. Eur J Cancer. 2001; 37: 189-197. (Pubitemid 32144695)
23. da Silva GM, Hull T, Roberts PL, et al. The effect of colorectal surgery in female sexual function, body image, self-esteem and general health: a prospective study. Ann Surg. 2008; 248: 266-272.
24. Gorlero F, Lijoi D, Biamonti M, et al. Hysterectomy and women satisfaction: total versus subtotal technique. Arch Gynecol Obstet. 2008; 278: 405-410.
25. Cella D, Hughes C, Peterman A, et al. A brief assessment of concerns associated with genetic testing for cancer: the Multidimensional Impact of Cancer Risk Assessment (MICRA) questionnaire. Health Psychol. 2002; 21: 564-572. (Pubitemid 35244769)
26. Wills CE, Holmes-Rovner M,. Preliminary validation of the Satisfaction With Decision scale with depressed primary care patients. Health Expect. 2003; 6: 149-159. (Pubitemid 36644600)
27. Berry DL, Ellis WJ, Russell KJ, Blasko JC, Bush N, Blumenstein B, et al. Factors that predict treatment choice and satisfaction with the decision in men with localized prostate cancer. Clin Genitourin Cancer. 2006; 5: 219-226. (Pubitemid 46190384)
28. Parhiscar A, Rosenfeld RM,. Can patient satisfaction with decisions predict compliance with surgery? Otolaryngol Head Neck Surg. 2002; 126: 365-370. (Pubitemid 41123556)
29. Elit L, Esplen MJ, Butler K, Narod S,. Quality of life and psychosexual adjustment after prophylactic oophorectomy for a family history of ovarian cancer. Fam Cancer. 2001; 1: 149-156.
30. Robson M, Hensley M, Barakat R, et al. Quality of life in women at risk for ovarian cancer who have undergone risk-reducing oophorectomy. Gynecol Oncol. 2003; 89: 281-287. (Pubitemid 36457877)
31. Tiller K, Meiser B, Butow P, et al. Psychological impact of prophylactic oophorectomy in women at increased risk of developing ovarian cancer: a prospective study. Gynecol Oncol. 2002; 86: 212-219. (Pubitemid 34953506)
32. Lostumbo L, Carbine N, Wallace J, Ezzo J,. Prophylactic mastectomy for the prevention of breast cancer [serial online]. Cochrane Database Syst Rev. 2004; (4): CD002748.
33. Barclay-Goddard R, Epstein JD, Mayo NE,. Response shift: a brief overview and proposed research priorities. Qual Life Res. 2009; 18: 335-346.
34. Peterson HB,. Sterilization. Obstet Gynecol. 2008; 111: 189-203.
35. Moseman CP, Robinson RD, Bates GW Jr, Propst AM,. Identifying women who will request sterilization reversal in a military population. Contraception. 2006; 73: 512-515.
36. Curtis KM, Mohllajee AP, Peterson HB,. Regret following female sterilization at a young age: a systematic review. Contraception. 2006; 73: 205-210. (Pubitemid 43087770)
37. Fang CY, Cherry C, Devarajan K, Li T, Malick J, Daly MB,. A prospective study of quality of life among women undergoing risk-reducing salpingo-oophorectomy versus gynecologic screening for ovarian cancer. Gynecol Oncol. 2009; 112: 594-600.